NCT00491010

Brief Summary

Patients undergoing atrial flutter ablation will be randomized to either the standard ablation approach or voltage targeted approach. Patients will be followed for one year to assess outcome of the ablation technique

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2006

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2006

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 25, 2007

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
Last Updated

June 25, 2007

Status Verified

June 1, 2007

First QC Date

June 21, 2007

Last Update Submit

June 21, 2007

Conditions

Atrial Flutter

Keywords

atrial flutterablationvoltage targeted

Interventions

radiofrequency catheter ablationPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing TV-IVC isthmus ablatin for atrial flutter

You may not qualify if:

  • atypical atrial flutter
  • \<18 years old any atrial surgery or pacemaker refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Center

London, Ontario, N6A 5A5, Canada

RECRUITING

MeSH Terms

Conditions

Atrial Flutter

Interventions

Catheter Ablation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Radiofrequency AblationRadiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Allan c Skanes, MD

    University of Western Ontario, London Health Sciences Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Allan Skanes, MD

CONTACT

519-685-8500askanes@uwo.ca

Lorne gula, MD

CONTACT

519 685-8500lgula@uwo.ca

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 21, 2007

First Posted

June 25, 2007

Study Start

July 1, 2006

Study Completion

February 1, 2008

Last Updated

June 25, 2007

Record last verified: 2007-06

Locations

CA(1)